Ceritinib dihydrochloride T1791L
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Ceritinib dihydrochloride is a selective, orally bioavailable and ATP-competitive inhibitor of ALK tyrosine kinase(IC50 of 200 pM), and also inhibits IGF-1R, InsR, and STK22D (IC50 values of 8, 7, and 23 nM, respectively), shows great antitumor potency
CAS nr:
1380575-43-8
Purity:
98%
Molecular Weight:
631,06
SMILES:
Cl.Cl.CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1
Formula:
C28H38Cl3N5O3S
Pathway:
Tyrosine Kinase/Adaptors,Angiogenesis,Tyrosine Kinase/Adaptors
Target:
ALK,ALK,IGF-1R
